The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia

Clinical Trial ID NCT00209027

Rank	Title	Journal	Year	PubWeight™‹?›
1	Implications of normal brain development for the pathogenesis of schizophrenia.	Arch Gen Psychiatry	1987	8.81
2	Limbic activation during cue-induced cocaine craving.	Am J Psychiatry	1999	6.66
3	Dopamine in schizophrenia: a review and reconceptualization.	Am J Psychiatry	1991	5.36
4	Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli.	Am J Psychiatry	2000	4.87
5	Drugs of abuse: anatomy, pharmacology and function of reward pathways.	Trends Pharmacol Sci	1992	4.57
6	Neural activity related to drug craving in cocaine addiction.	Arch Gen Psychiatry	2001	3.84
7	Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.	J Pharmacol Exp Ther	2002	3.67
8	Dissociable neural responses in human reward systems.	J Neurosci	2000	3.39
9	Differential response patterns in the striatum and orbitofrontal cortex to financial reward in humans: a parametric functional magnetic resonance imaging study.	J Neurosci	2003	2.96
10	Characterizing stimulus-response functions using nonlinear regressors in parametric fMRI experiments.	Neuroimage	1998	2.51
11	Functional magnetic resonance imaging of cocaine craving.	Am J Psychiatry	2001	2.14
12	Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort.	Arch Gen Psychiatry	1986	1.42